Category: Press Release - Page 65 - Psychedelic Alpha

Read more about the article Numinus Wellness Inc. Reports Q2 2022 Results

Numinus Wellness Inc. Reports Q2 2022 Results

Post published:April 14, 2022
Post category:Press Release

Read more about the article Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT

Cybin Announces Positive CYB004 Data Demonstrating Significant Advantages Over Intravenous and Inhaled DMT

Post published:April 13, 2022
Post category:Press Release

Read more about the article Filament Health Is Issued Patent By United States Patent And Trademark Office

Filament Health Is Issued Patent By United States Patent And Trademark Office

Post published:April 13, 2022
Post category:Press Release

Read more about the article Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

Awakn Life Sciences Provides Shareholder Update on Three Operational Ketamine-Assisted Therapy Clinics in the UK and Norway

Post published:April 13, 2022
Post category:Press Release

Read more about the article Mydecine Announces Reverse Stock-Split

Mydecine Announces Reverse Stock-Split

Post published:April 13, 2022
Post category:Press Release

Read more about the article PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production Process of Ketamine and Ketamine Analogs

PharmaTher Signs Exclusive Worldwide License Agreement for Patented Formulation and Production Process of Ketamine and Ketamine Analogs

Post published:April 12, 2022
Post category:Press Release

Read more about the article Filament Health Announces Pre-IND Meeting With United States Food And Drug Administration

Filament Health Announces Pre-IND Meeting With United States Food And Drug Administration

Post published:April 12, 2022
Post category:Press Release

Numinus to Acquire Novamind, Creating the North American Industry Leader in Psychedelic Therapy and Research

Post published:April 12, 2022
Post category:Press Release

Read more about the article Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery of Multiple Psychedelic Molecules

Cybin Announces Publication of International PCT Patent Application for Inhalation Delivery of Multiple Psychedelic Molecules

Post published:April 8, 2022
Post category:Press Release

Read more about the article Core One Labs’ Upgrades to OTCQB Venture Market

Core One Labs’ Upgrades to OTCQB Venture Market

Post published:April 6, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.